BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 卷:18 |
Novel bis-(arylsulfonamide) hydroxamate-based selective MMP inhibitors | |
Article | |
Subramaniam, Rajesh2  Haldar, Manas K.2  Tobwala, Shakila1  Ganguly, Bratati1  Srivastava, D. K.1  Mallik, Sanku2  | |
[1] N Dakota State Univ, Dept Chem Biochem & Mol Biol, Fargo, ND 58105 USA | |
[2] N Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA | |
关键词: MMP inhibitors; bis-(arylsulfonamide); hydroxamate; | |
DOI : 10.1016/j.bmcl.2008.04.035 | |
来源: Elsevier | |
【 摘 要 】
A series of bis-(arylsulfonamide) hydroxamate inhibitors were synthesized. These compounds exhibit good potency against MMP-7 and MMP-9 depending on the nature, steric bulk, and substitution pattern of the substituents in the benzene ring. In general, the preliminary structure-activity relationships (SAR) suggest that among the DAPA hydroxamates (i) electron-rich benzene rings of the sulfonamides may produce better inhibitors than electron-poor analogs. However, potential H-bond acceptors can reverse the trend depending on the isozyme; (ii) isozyme selectivity between MMP-7 and-9 can be conferred through steric bulk and substitution pattern of the substituents in the benzene ring, and (iii) the MMP-10 inhibition pattern of the compounds paralleled that for MMP-9. (C) 2008 Elsevier Ltd. All rights reserved.
【 授权许可】
Free
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
10_1016_j_bmcl_2008_04_035.pdf | 175KB | download |